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Background: Systemic-to-pulmonary collateral flow (SPCF) may constitute a risk factor for increased morbidity and
mortality in patients with single-ventricle physiology (SV). However, clinical research is limited by the complexity of multi-
vessel two-dimensional (2D) cardiovascular magnetic resonance (CMR) flow measurements. We sought to validate four-
dimensional (4D) velocity acquisition sequence for concise quantification of SPCF and flow distribution in patients with SV.
Methods: 29 patients with SV physiology prospectively underwent CMR (1.5 T) (n= 14 bidirectional cavopulmonary
connection [BCPC], age 2.9± 1.3 years; and n=15 Fontan, 14.4 ± 5.9 years) and 20 healthy volunteers (age,
28.7± 13.1 years) served as controls. A single whole-heart 4D velocity acquisition and five 2D flow acquisitions were
performed in the aorta, superior/inferior caval veins, right/left pulmonary arteries to serve as gold-standard. The five 2D
velocity acquisition measurements were compared with 4D velocity acquisition for validation of individual vessel flow
quantification and time efficiency. The SPCF was calculated by evaluating the disparity between systemic (aortic minus
caval vein flows) and pulmonary flows (arterial and venour return). The pulmonary right to left and the systemic lower to
upper body flow distribution were also calculated.
Results: The comparison between 4D velocity and 2D flow acquisitions showed good Bland-Altman agreement
for all individual vessels (mean bias, 0.05±0.24 l/min/m2), calculated SPCF (−0.02±0.18 l/min/m2) and significantly
shorter 4D velocity acquisition-time (12:34 min/17:28 min,p< 0.01). 4D velocity acquisition in patients versus
controls revealed (1) good agreement between systemic versus pulmonary estimator for SPFC; (2) significant
SPCF in patients (BCPC 0.79±0.45 l/min/m2; Fontan 0.62±0.82 l/min/m2) and not in controls (0.01 + 0.16 l/min/m2),
(3) inverse relationof right/left pulmonary artery perfusion and right/left SPCF (Pearson=−0.47,p= 0.01) and (4) upper to
lowerbody flowdistribution trend related to theweight (r = 0.742, p< 0.001) similar to the controls.
Conclusions:4Dvelocity acquisition is reliable, operator-independent andmore time-efficient than 2D flowacquisition to
quantify SPCF. There is considerable SPCF inBCPCandFontanpatients. SPCFwasmorepronounced towards the
respective lungwith less pulmonary arterial flow suggestingmore collateral flowwhere less anterogradebranch
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Systemic-to-pulmonary collateral flow (SPCF, Figure 1)
often develops in patients with univentricular heart physi-
ology after bidirectional cavopulmonary connection
(BCPC) or Fontan-type palliation although little is known
about their true prevalence [1]. Hemodynamically, SPCF
may result in competitive pulmonary perfusion and power
loss in the Fontan pathway by transferring kinetic energy to
the distal pulmonary vasculature, and in volume loading of
the systemic single-ventricle [2]. The relevance of SPCF in
terms of morbidity and mortality of patients with univentri-
cular heart physiology remains controversial due to lack of
reproducible quantitative noninvasive methods to assess
SPCF. Recently, Whitehead and colleagues introduced a
new method to non-invasively quantify SPCF using two-
dimensional phase-contrast (2D flow) cardiac magnetic
resonance (CMR) velocity mapping in single-ventricle
patients after superior BCPC [2]. Two different estimators
of SPCF were proposed, namely, the difference betweenFigure 1 Scheme of systemic and pulmonary circulation. (A) Normal p
permeable. (B) Collateral circulation: There is a shunt network between the
are 1) the aortopulmonary collaterals (between the bronchial artery and th
bronchial vein and the pulmonary vein) and 3) the arterio-venous shunts (d
the capillary network). Adapted from Heimburg P [4], copyright notice 2011,aortic and caval flow (systemic estimator), and the differ-
ence between pulmonary venous and pulmonary arterial
flow (pulmonary estimator); and close agreement was
observed for both approaches. This allows for internal
validation of SPCF quantification, which is highly
important, as no other gold-standard method exists [2].
However, this technique (as well as similar approaches [3])
is complex as multiple 2D flow measurements are required
to determine SPCF (both caval veins, ascending/descending
aorta, branch pulmonary arteries, pulmonary veins). Hence,
although non-invasive and quantitative, this technique is
lengthy and highly dependent on operator skills, which
makes it cumbersome for larger-scale prospective clinical
research needed to further, elucidate the clinical role of
SPCF after staged repair of single-ventricle physiology.
In this context, we propose the use of whole-heart
four-dimensional (4D) velocity acquisition phase-contrast
CMR flow to quantify the SPCF contributing to pulmonary
perfusion. The 4D velocity acquisition scan can be plannedhysiology: The virtual network connections are present but are not
systemic and the pulmonary circulation. These shunting connections
e pulmonary artery), 2) the veno-venous collaterals (between the
irect connections between the bronchial artery and vein bypassing
with permission from BMJ Publishing Group Ltd.
Table 1 Summary of the patients’ demographic data,
primary diagnosis and type of palliated surgery
BCPC Fontan p value
Age at CMR (years) 2.9 ± 1.3 14.4 ± 5.9 0.01*
Weight (kg) 12.5 ± 3.1 46.2 ± 22 0.01*
BSA (m2) 0.5 ± 0.1 1.4 ± 0.4 0.01*
Females (%) 8 (57 %) 4 (27 %) >0.05
Age at BCPC (years) 0.6 ± 0.2 1.1 ± 0.8 0.01*
Time between BCPC – CMR (years) 2.3 ± 1.3 11.4 ± 3.1 0.01*
Age at Fontan (years) - 5.7 ± 6.5 -
Time between BCPC-Fontan (years) - 2.9 ± 1.3 -
Time between Fontan – CMR (years) - 8.6 ± 4.1 -
Primary cardiac diagnosis
Double inlet left ventricle 1 4 n/a
Tricuspid atresia 1 3 n/a
PA – IVS 2 - n/a
HLHS 10 5 n/a
Unbalanced AVSD 1 2 n/a
Straddling AV valve - 1 n/a
Staged palliated surgery
Hemi-Fontan 11 - n/a
BCPC 3 - n/a
Classic Fontan (Atriopulmonary connection) - 4 n/a
Intracardiac Lateral tunnel - 2 n/a
Extracardiac Conduit - 9 n/a
AV, atrioventricular valve; AVSD, atrioventricular septal defect; BCPC,
bidirectional cavopulmonary connection; BSA, body surface area; CMR,
cardiovascular magnetic resonance; HLHS, hypoplastic left heart syndrome; PA
- IVS, pulmonary atresia and intact ventricular septum; TCPC, total
cavopulmonary connection; n/a, not applicable; *, p< 0.05.
Valverde et al. Journal of Cardiovascular Magnetic Resonance 2012, 14:25 Page 3 of 11
http://www.jcmr-online.com/content/14/1/25as a simple box covering the whole mediastinal cardiovas-
cular system. The sequence has been already validated for
healthy adults [5], but not for patients with single-ventricle
physiology. Therefore, the purpose of this two-centre
prospective study is firstly to validate the use of 4D vel-
ocity acquisition for non-invasive quantification of
SPCF against 2D flow measurement [3,6] in patients
after BCPC or Fontan-type palliation; and secondly,
from the validated 4D velocity acquisition data, to com-
pare the systemic and pulmonary estimator for SPCF
between patients and controls. We hypothesized that
[1] there would be more SCPF in BCPC than Fontan,
[2] that anterograde versus collateral pulmonary perfu-
sion of either lung might be inversely related, and [3] that




The institutional review boards of both institutions
approved all protocols and written and signed consent
for research and publishing purposes was obtained from
each patient or their legal guardians.
This prospective two-centre study included 29 successive
patients with univentricular heart physiology who were re-
ferred for routine CMR investigation at either Evelina Chil-
dren’s Hospital, Guy’s & St. Thomas’ Hospitals in London,
United Kingdom (12 BCPC, 8 Fontan) or at the German
Heart Institute in Berlin, Germany (2 BCPC, 7 Fontan) be-
tween March 2010 and February 2011.
The BCPC group (n = 14) mean age was 2.9 ± 13 years,
with a female/male ratio of 8/6. The Fontan group
(n = 15) mean age was 14.4 ± 5.9 years and the female/
male ratio was 4/11. No patient had previous diagnosis
or suspicion of relevant SPCF. Exclusion criteria were:
Arrhythmia, inlet or outlet valvular incompetence, re-
sidual flow across surgical shunts, residual anterograde
flow into the pulmonary artery. The demographic data are
summarized in Table 1. Additionally, 20 controls (mean
age 28.7± 13.1 years, 9 females / 11 males) underwent 4D
velocity acquisition scanning to evaluate the presence of
SPCF (n= 13 controls at Guy’s & St. Thomas’ Hospital,
n = 7 at the German Heart Institute, Berlin).
CMR studies
All CMR scans were performed on a whole-body 1.5 T
Achieva MR scanners (Philips Medical Systems, Best, The
Netherlands) with either a 5-channel or 32-channel cardiac
surface coil. Patients younger than 10 years were examined
under general anaesthesia or conscious sedation. All
patients underwent clinical CMR investigations according
to a uniform study protocol to investigate the cardiovascu-
lar anatomy, ventricular function (multi-slice steady-state
free precession) and patency of the BCPC or Fontancircuits. Additionally, hemodynamic quantification of SPCF
was investigated by using phase-contrast CMR 2D and 4D
velocity acquisition as detailed below. The controls under-
went 4D velocity acquisition scanning for validations pur-
poses but no 2D flow acquisitions as 4D velocity
acquisition versus 2D flow validation has been published
previously [5].
Two-dimensional phase-contrast flow
Standardized localizer imaging planes were first acquired to
plan 2D flow acquisitions across five targeted vessels: super-
ior vena cava (SVC), inferior vena cava (IVC), right pul-
monary artery (RPA), left pulmonary artery (LPA) and
ascending aorta (AO). Care was taken to align the plane
perpendicular to flow and to obtain slice positions that were
inferior to the vena azygos insertion into the SVC, and mid-
way between pulmonary bifurcation and distal branching
for both pulmonary arteries. Free-breathing 2D phase-con-
trast sequences were then obtained in the five targeted ves-
sels using the CMR parameters described in Table 2.






Field of view (mm) 150 x 300 200 x 300
Acquired voxel size (mm) 2.3 x 2.3 x 7 2.4 x 2.5 x 2.5
Reconstructed voxel size (mm) 1.2 x 1.2 x 7 1.5 x 1.5 x 2.3
Number of slices 1 25-40
Cardiac gating Retrospective Retrospective
Respiratory motion Non-gated Non-gated
Free breathing Free breathing
NSA 2 1
TR(ms)/TE(ms) 5/3 3.2 /1.9
Flip angle (°) 10 5
SENSE No 2
Reconstructed cardiac phases 35-40 22-25
VEC (cm/s) 60-100 (venous vessels)
200–400 (arterial vessels)
150-400
2D, two-dimensional; 4D, four-dimensional; CMR, cardiovascular magnetic
resonance; NSA, number of signal averages; SENSE, sensitivity encoding for
fast CMR; TR, repetition time; TE, echo time; VEC, velocity encoding.
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A free-breathing non-respiratory-gated 4D velocity acqui-
sition sequence covering the whole heart and great vessels
within the mediastinum was acquired using the CMR
parameters detailed in Table 2. The maximal velocity
encoded values (VENC) were predefined based on the
maximal velocity measured in the analyzed vessels by
previous echocardiography. The same VENC was set in
the three spatial directions. For 4D and 2D phase-contrast
flow scans, the time for both data acquisition and scan
planning was measured. Repeated 2D flow acquisitions
due to plane misalignment or velocity aliasing were also
included in the total time.
Flow data post-processing
2D flow analysis was performed in an Extended MR
Workspace station (Version 2.5.3.1, Philips Healthcare,
Best, The Netherlands). The region of interest in each tar-
geted vessel was manually traced in every cardiac phase to
obtain the average flux along one cardiac cycle, indexed to
body surface area (BSA, l/min/m2).
The 4D velocity acquisition data was analyzed using
the software ‘GTFlow’ (Release 1.5.4, Gyrotools, Zurich,
Switzerland). The 4D velocity acquisition data was re-
formatted along the five targeted vessel using the geom-
etry imported from the 2D imaging planes (Figure 2).
Thereafter, the region of interest was then traced manually
in the same way as for 2D flow acquisition. Additionally,
flux was also obtained in the individual right pulmonaryveins (RPV) and left pulmonary veins (LPV) by manu-
ally reformatting the 4D velocity acquisition data into a
plane perpendicular to each vessel.
All 2D and 4D velocity acquisitions were assessed by two
independent observers with over three years of experience
in CMR.
Statistical analysis and calculations
Continuous variables are presented as mean ± standard
deviation (SD). Statistical analysis was performed using
SPSS software (version 17; SPSS, Chicago, Ill). A p-value
less than 0.05 was considered to indicate statistically sig-
nificant differences. Demographic data differences be-
tween patient groups were evaluated by Student t-test and
Chi-square test.
Validation of 4D versus 2D velocity acquisition
The agreement between 2D flow acquisition and 4D vel-
ocity acquisition for the five individual vessels flow in
patients with univentricular heart physiology was evalu-
ated by Bland-Altman plot analysis and their correlation
assessed by Pearson correlation analysis. Intra- and inter-
observer variance for repeated 2D and 4D velocity ac-
quisition vessel measurements was evaluated by
intraclass correlation coefficient (ICC). Time difference
between 2D flow and 4D velocity acquisitions was eval-
uated by paired t-test.
Evaluation of SPCF
The SPCF can be calculated by evaluating the systemic
flow estimator [AO-(SVC-IVC)] or the pulmonary flow
estimator [(RPV+LPV)-(RPA-LPA)] disparity (seeTable 3).
The agreement between 2D and 4D velocity acquisition
for SPCF calculation using the systemic flow method was
evaluated by Bland-Altman plot analysis and their correl-
ation by the Pearson correlation analysis, as was the in-
ternal 4D velocity acquisition validation for the systemic
versus pulmonary flow estimator of SPCF. Evaluation of
quantitative SPCF for BCPC/Fontan/controls was assessed
by paired t-test. Multiple regression analysis was used to
evaluate significant correlation of SPCF with independent
variables (age at BCPC, time since the BCPC operation,
age at Fontan, time since Fontan operation, ventricular
end-diastolic volume and pulmonary [Qp] to systemic
[Qs] flow ratio).
Pulmonary right to left flow distribution
The distribution of the blood flow for BCPC/Fontan/
controls between the right and left lung was evaluated
by 4D velocity acquisition in terms of pulmonary arterial
flow (RPA+LPA) and venous return (RPV+LPV)
(Table 3) and evaluated by paired t-test. The Pearson test
was performed to evaluate the SPCF and pulmonary ar-
tery flow correlation.
Figure 2 4D velocity acquisition plane location for flow investigation. (A) Anterior view of the Fontan circuit and aortic arch with visualized
pathlines within the IVC, LPA, RPA and SVC. (B) Posterior view of the Fontan circuit, aortic arch and pulmonary veins with visualized pathlines
within the pulmonary veins. (C) Sagittal view of the aortic arch with visualized pathlines. AO, aorta; IVC, inferior vena cava; LLPV, left lower
pulmonary veins; LPA, left pulmonary artery; LUPV, left upper pulmonary veins; RLPV, right lower pulmonary veins; RPA, right pulmonary artery; RUPV,
right upper pulmonary veins.
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The percentage of IVC (%) related to the total systemic
venous return [IVC/(IVC+ SVC)*100] was also evaluated
for patients with univentricular heart physiology and
controls (Figure 3). A multiple regression analysis was
used to evaluate the correlation of IVC-percentage with
independent variables (weight, height and BSA).
Results
Baseline characteristics
Patient’s characteristics are summarized in Table 1. BCPC
and Fontan patients were significantly different in terms of
age at the investigation, weight and body surface area
(BSA) (p< 0.001). Age at BCPC surgery was significantly
lower in the BCPC group than in the Fontan group. The
mean age of the control group was 28.7±13.1 years, mean
weight 66±19 kg and mean BSA 1.7±0.4 m2. All 49 CMR
investigations were completed successfully. There were no
statistically significant differences in the female to male
ratio between BCPC, Fontan and Control groupsTable 3 Calculated parameters blood flow parameters
Derived equations
Systemic blood flow (QS)
Traditional (Systemic arterial supply) AO
New (Systemic venous return) SVC + IVC
Pulmonary blood flow (QP)
Traditional (Pulmonary arterial supply) RPA+ LPA
New (Pulmonary venous return) RPV + LPV
Systemic-to-pulmonary collateral flow (SPCF)
Systemic flow estimator (AO) – (SVC+ IVC)
Pulmonary flow estimator (RPV+ LPV) - (RPA+ LPA)
AO, aorta; IVC, inferior vena cava; LPA, left pulmonary artery; LPV, left
pulmonary veins; RPA, right pulmonary artery; RPV, right pulmonary veins;
SPCF, systemic-to-pulmonary collateral flow; SVC, superior vena cava.(p= 0.245). Twenty 2D flow sequences were repeated due
to plane malalignment or velocity aliasing. No 4D sequence
had to be repeated. The average time to satisfactorily obtain
the five individual 2D flow scans (17:28±04:24 min) was sig-
nificantly longer than the single 4D velocity acquisition se-
quence (12:34±03:42 min, p< 0.01). The mean indexed
end-diastolic and end-systolic ventricular volumes were
85.8± 24.2 ml/m2 and 36.4± 19.8 ml/m2 for BCPC and
91.7± 21 ml/m2 and 41 ± 15.7 ml/m2 for Fontan patients
respectively. The ejection fraction was 61.8 ± 8 % for the
BCPC and 56.4± 10.3 % for Fontan patients. In 15
patients we found some degree of atrioventricular valve
incompetence (mild to moderate).
Validation of 4D velocity acquisition versus 2D flow
measurements in patients
In all patients, 4D velocity acquisition and the 2D
flows were comparable for all investigated vessels
(Bland-Altman mean difference 0.05±0.24 l/min/m2) as
shown in Table 4 and Figure 4A. This was also
reflected by the excellent Pearson coefficient (Table 4)
and correlation trend-line (R2 = 0.88, Figure 4B). Intra-
and interobserver variability for all the individual ves-
sels was excellent for 2D velocity flow (ICC> 0.97,
95 % confidence interval 0.96-0.99) and also for 4D
velocity acquisition (ICC> 0.95, 95 % confidence inter-
val 0.91-0.97). The calculated systemic-to-pulmonary
collateral flow (SPCF) by systemic estimator (AO)–
(SVC+ IVC) [2] in patients with univentricular heart
physiology showed good agreement between 2D velocity
acquisition and 4D velocity acquisition (Bland-Altman
analysis, mean difference −0.02±0.18 l/min/m2) with
good correlation (Pearson correlation coefficient 0.73, p
< 0.05, Table 4). The 4D velocity acquisition internal
validation SPCF calculation by systemic versus pul-
monary estimator (Table 3) showed good agreement
with some scatter (mean bias 0.01±0.78 l/min/m2). We
chose the pulmonary estimator method as it allowed
Figure 3 Systemic lower to upper body flow ratio in patients and controls. Inferior vena cava to total systemic venous flow ratio
[IVC:(IVC+SVC)] to show the lower to upper body flow relationship changes with body weight. The patient’s data (circle) and trend-line (R2=0.406)
shows similar distribution to the control data (squares).
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used subsequently for the 4D velocity acquisition-based
sub-analyses as detailed below.
4D velocity acquisition for SPCF: patients versus controls
Table 5 summarizes the flow data in controls. There was
no significant SPCF in the control group (−0.01±0.16 l/









SVC 1.77±0.61 1.62±0.61 0.93±0.34
IVC 1.79±1.01 1.74±1.05 1.80±0.63
RPA 1.06±0.37 1.01±0.36 1.43±0.51
LPA 0.79±0.37 0.77±0.44 1.12±0.28
AO 3.61±1.21 3.57±1.16 3.08±0.70
SPCF 0.59±0.52 0.79±0.45 0.41±0.46
Qp:Qs (0.43±0.23):1 (0.42±0.23):1 (0.82±0.29):1
Values expressed as l/min/m2. *statistically significant correlation; 2D, two-dimensio
CMR, cardiovascular magnetic resonance; IVC, inferior vena cava; LPA, left pulmonar
pulmonary artery; SPCF, systemic-to-pulmonary collateral flow (SPCF =AO-SVC-IVC);using the pulmonary estimator (SPCF, Figure 4) in
patients with BCPC (0.79±0.45 l/min/m2, p< 0.05) and
Fontan (0.56±0.81 l/min/m2, p< 0.05). For BCPC
patients, SPCF represented 25.8±20.2 % of total Qp (pul-
monary venous return), and 17.8±15.4 % of total Qs
(aortic outflow). For Fontan patients, SPCF represented
19.7±26.4 % of total Qp (pulmonary venous return) and
21.0±26.8 % of total Qs (aortic outflow).alues and agreement of 2D and 4D velocity acquisition





2D - 4D velocity
acquisition
2D - 4D velocity
acquisition
0.92±0.35 0.07 ± 0.04 0.96 *
1.64±0.55 0.11 ± 0.01 0.93 *
1.47±0.59 0.01 ± 0.05 0.91*
1.10±0.33 0.02 ± 0.05 0.94*
3.04±0.56 0.04 ± 0.05 0.94*
0.62±0.82 −0.02 ± 0.18 0.73*
(0.84±0.26):1 (0.02 ± 0.18):1 0.82*
nal; 4D, four-dimensional, AO, aorta; BCPC, bilateral cavopulmonary connection;
y artery; Qp, pulmonary blood flow; Qs, systemic blood flow; RPA, right
SVC, superior vena cava.
Figure 4 2D and 4D velocity acquisition comparison charts in patients with univentricular heart physiology. A. Bland-Altman agreement
graph. B. Correlation scatter-plot. 2D, two-dimensional; 4D, four-dimensional; AO, aorta; IVC, inferior vena cava; LPA, left pulmonary artery; RPA,
right pulmonary artery; SVC, superior vena cava.
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ciated with ventricular end-diastolic or end-systolic vol-
ume, ventricular ejection fraction, age at (or time since)
BCPC/Fontan operation, respectively.
4D velocity acquisition: pulmonary right to left flow distribution
For BCPC and Fontan patients, there was a preferential
flow via the pulmonary arteries to the right lung, as seen in
the control group (p< 0.01, Figure 5). Preferential SPCF
however was towards the left lung (p< 0.05), with inverseTable 5 Controls: demographics and 4D CMR flow data
Demographics
Controls (n) 20
Age at CMR (years) 28.7±13.1
Weight (kg) 65.9±19.2
BSA (m2) 1.7±0.4
Females (%) 9 (41 %)
4D velocity acquisition (l/min/m2)
SVC 0.91±0.14
IVC 1.8±0.43
RPA 1.48 ± 0.28
LPA 1.26 ± 0.25
RPV 1.45 ± 0.29
LPV 1.28 ± 0.25
AO 2.74±0.45
SPCF −0.01±0.16
4D, four-dimensional; AO, aorta; BSA, body surface area; CMR, cardiovascular
magnetic resonance; IVC, inferior vena cava; LPA, left pulmonary artery; LPV,
left pulmonary veins; RPA, right pulmonary artery; RPV, right pulmonary veins;
SVC, superior vena cava; SPCF, systemic-to-pulmonary collateral flow
(SPCF = RPV+ LPV-RPA-LPA).correlation of pulmonary artery inflow and SPCF to the re-
spective lung (Pearson=−0.48, p< 0.05).
4D velocity acquisition: systemic venous flow distribution
(IVC/SVC)
The IVC to total systemic venous return percentage
[(IVC/(IVC + SVC)*100] changed from 50 % in younger
patients up to 75 % in larger patients (Figure 3). A mul-
tiple regression analysis including age, weight, height
and BSA revealed that the weight is the best independent
variable to predict the IVC percentage ratio in patients
with univentricular heart physiology (r = 0.742, p< 0.001).
This trend was also seen in the controls (Figure 3).
Discussion
4D versus 2D velocity acquisition for SPCF quantification
in single-ventricle palliation
In this first study using 4D velocity acquisition to
assess quantitative pulmonary perfusion after univen-
tricular heart palliation study, we have shown that
4D velocity acquisition-based SPCF determination is
simple, more time-effective and accurate when com-
pared with 2D velocity acquisition. Previous valid-
ation of 4D velocity acquisition against the gold-
standard of 2D velocity acquisition was mainly performed
in adult volunteers [5,7] with only a small number of
pediatric patients with miscellaneous congenital heart
diseases included [5]. 4D velocity acquisition technique
had a good observer reproducibility and agreement with
2D velocity acquisition being the current gold-standard
method for vessel flow quantification [8]. 4D velocity
acquisition allowed for straight-forward internal valid-
ation of calculated SPCF by either systemic flow or pul-
monary flow estimator (see Table 3) [2]. In this clinical
setting, 4D velocity acquisition has principle advantages
Figure 5 Pulmonary right to left lung blood flow distribution calculated by 4D velocity acquisition evaluated in terms of arterial blood
supply (pulmonary arteries) and venous return (pulmonary veins). The flow difference between the pulmonary veins and the pulmonary
arteries is represented by the systemic aortopulmonary collaterals (APC). *=Statistically significant difference.
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to-plan scan, all vessels of interest are acquired; [2] in-
vestigation of unsuspected vascular connections not
appreciated during the scanning procedure are eligible to
quantitative evaluation during post-processing which is
obviously not possible with 2D velocity acquisition; [3]
free image-plane reformation during post-processing
allows investigation at any vessel location avoiding stent
artifacts or velocity aliasing. Hence, our data suggest su-
periority of 4D velocity acquisition over conventional
multi-site 2D velocity acquisition to quantify SPCF in
staged Fontan-type palliation and may replace 2D CMR
flow in this important clinical setting.
Clinical impact
In this context, due to its simplicity, the 4D velocity
acquisition method may prove useful in prospective
clinical research to elucidate the clinical importance of
SPCF magnitude in the evolution of the failing Fontan
circulation. Although the sample size was relatively small
for each group, our study generated first data in this con-
text using the 4D velocity acquisition approach, which
relates to previous findings and provides new information.
1. We found no significant SPCF in n = 20 controls.
Due to the variety of applied methods to quantify
SPCF, it has previously been difficult to establish
‘normal’ SPCF values although some numbers were
reported to be in the order of 7 % of the cardiac
output [9].
2. There was significant SPCF in our two patient groups.
In the BCPC group we measured 0.71±0.57 l/min/m2
which represented 25.8±20.2 % of total Qp
(=pulmonary venous return) whilst in the Fontan
group SPCF was slightly less with 0.56±0.81 l/min/m2representing 19.7±26.4 % of total Qp. In other words,
SPCF contributed around 18-21 % of the total
systemic (aortic) flow.
This amount of left-to-right shunting is considerable
albeit not massive, and hence it was no surprise that
we were unable to find any correlation of SPCF
magnitude with single ventricle sizes or systolic
function (i.e., end-diastolic/end-systolic volumes and
ejection fraction) for either patient group. This is in
contrast with findings published recently by
Whitehead and colleagues who did observe such
correlation [2] but available sample sizes from both
studies (<20 subjects for each respective patient
group) may be too small to allow meaningful
conclusions in either direction in terms of relevance
of SPCF for progressive ventricular dilatation and
dysfunction in Fontan patients. This will require
much larger numbers and a multicenter study design
with consistent operator-independent flow
quantification and central core-lab image reading
facilities. We feel that the proposed validated 4D
velocity acquisition technique may be useful for such
an undertaking.
3. In our unselected group of BCPC and Fontan patients,
the observed SPCF numbers were generally smaller
than previously reported by using other methods for
quantification. In the BCPC group for example, the
SPCF was previously reported as mean of 1.75±0.46 l/
min/m2 by a combined approach with nuclear imaging
and catheterization [10] whilst Grosse-Wortmann et al.
using CMR 2D velocity acquisition recently suggested a
median 0.78 and 1.42 l/min/m2, depending on whether
either the systemic estimator or the pulmonary
estimator was used for calculation [3]. Whitehead et
al. did not observe such discrepancy in their cohort
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indexed SPCF of 0.5 to 2.8 l/min/m2 (=11 % to 53 %
(mean, 37 %) of aortic flow, and 19 % to 77 %
(mean, 54 %) of pulmonary venous return. In our
study we observed in the Fontan patient cohort,
our calculated SPCF (mean 0.56±0.81 l/min/m2)
was comparable to that by Groose-W et al. [3]
(median 0.82 l/min/m2).
These discrepancies are likely due to
methodological constrains as explained above, but
also possibly due to selection bias with higher
likelihood of inclusion of patients with known
aorto-pulmonary collateral arteries when
investigating SPCF quantification.
4. Our study corroborates the reported regression in the
magnitude of SPCF from BCPC to Fontan stages [3]. In
patients with BCPC, where the pulmonary blood flow
is limited to nearly half of the venous return (SVC), the
development of SPCF is greater than in Fontan patients
(SPCF and Qp:Qs regression analysis, r = −0.47, p =
0.01).
5. Interestingly, we observed an inverse relation of
anterograde pulmonary artery inflow and the
magnitude of the SPCF to the respective lung (Pearson
−0.48, p = 0.001). In accordance with previously
reported data [6], we found preferential anterograde
flow towards the right lung, which was slightly more
pronounced in BCPC (57.1 % to RPA versus 42.9 % to
LPA, p = 0.07) than in the Fontan patients (56.9 %
versus 43.1 %, p = 0.01) and in the control group
(54.9 % versus 45.1 %, p = 0.001). It is tempting to
speculate that the SPCF develops predominantly
towards lung territories with relatively reduced
anterograde arterial perfusion. Although this would
need confirmation in larger series with a wider range of
disparate right/left lung arterial perfusion, it seems to
underscore the clinical experience of more
collateralization in more severely underperfused lungs.
It has been suggested that a combination of elements
[3] such as reduced blood flow to one region of the
lungs [4], reduced pulsatility and velocity profiles [11],
high transpulmonary gradient or systemic
undersaturation [12] or humoral factors [13] might be
involved, but this still remains unclear.
6. In terms of the increase in IVC fraction of total
systemic venous return over time, this is the first study
to include both BCPC and Fontan patients. Our data
are consistent with previous studies in normal children
[14] and Fontan patients [6], reflecting that changes in
systemic blood flow distribution is barely affected by
staged palliated surgery.
Finally, although not focus of the present study, we also
would like to state the great potential of 4D velocityacquisition for visualization of blood flow patterns
allowing to estimate kinetic energy distribution and
qualifying to set up boundary conditions for computa-
tional fluid dynamic research [15]. The evaluation of
particle traces in Fontan patients has been performed
systematically in previous studies[16,17] and may help
understanding the low mechanics and in-efficient
hemodynamics which may contribute to the pathophysi-
ology of the failing Fontan circulation (See Additional
file 1: Video S1 and Additional file 2: Video S2). In fu-
ture studies a combination of APC flow quantification
and description of flow patterns in relation to clinical
outcome in patients with univentricular hearts might be
very promising.
Limitations
It is known that 4D velocity acquisition can be subject
to error from non-flow-related phase shifts due to eddy
currents and concomitant gradient fields, limited tem-
poral and spatial resolution and respiratory compensate
motion [5,7,18]. Although more research is needed to
quantify such effects, 4D velocity acquisition is a novel
technique under continuous development and improve-
ment (for example, time-efficient respiratory gating and
novel undersampling strategies to improve acquisition
speed), and hence we expect even higher levels of accur-
acy in future application [15]. For venous and Fontan
pathway flows, the settings of velocity-encoding values
(VENC) were higher for 4D velocity acquisition than in
targeted 2D velocity acquisition scans which may have
contributed to some of the observed scatter [18]. Due
to the presence of atrioventricular valve regurgitation
we could not include a comparison analysis between
ventricular stroke volumes from multi-slice steady-state
free precession with those obtained from 4D velocity
encoded in the aorta.
The use of mechanical ventilation and intravenous Pro-
pofol for general anaesthesia in younger patients could
have lead to altered flow through the pulmonary and
systemic circulations. One could speculate that higher
intrathoracic pressure leads to reduced passive venous
return through the Fontan circulation, combined with
reduced systemic pressure this might lead to a reduction
in overall APC flow.
It is a known dilemma that the majority of magnetic
resonance scanners are positioned supinely. Thus, the
influence of gravity on Fontan flow cannot be studied
accurately with MR imaging. However, previous stud-
ies have used Doppler imaging to assess the influence
of gravity on Fontan flow. The work of Hsia et al. [19]
indicates that gravity decreases net venous flow and
increases retrograde venous flow in Fontan patients.
Since in our study, Hemifontan and Fontan patients
were studied in supine position, the amount of APC
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more relevant upright position.
In our study we used a standardized protocol, in
which 4D flow measurements were always performed
after the 2D flow measurements. The time difference
between both flow measurements was approximately
15 minutes, thus, we believe it is unlikely that a
relevant bias was introduced, however, a systematic
error of this approach cannot be fully excluded.Conclusions
We have shown that 4D velocity acquisition is a reliable
and accurate technique, which is more time efficient than
2D velocity acquisition for quantitative analysis of sys-
temic and pulmonary perfusion including SPCF after palli-
ation of single-ventricle physiology. SPCF was found to be
present in both BCPC and Fontan patients and approxi-
mates 20-26 % of pulmonary venous return, and 18-21 %
of aortic output. There was no obvious association of
SPCF with ventricular dilatation or systolic function.
There was an inverse relation of branch pulmonary
arterial flow and SPCF to the respective lung, suggest-
ing that SPCF may develop predominantly where an-
terograde flow is reduced (or vice versa). The 4D
velocity acquisition approach has great potential be-
yond these observations to add further valuable infor-
mation about kinetic energy distribution and aid
computer fluid dynamics modeling approaches to
optimize Fontan pathway flow dynamics. Hence, 4D
velocity acquisition method may be useful in prospective
studies to investigate pulmonary flow mechanics including
SPCF to evaluate their impact on outcome late after pal-
liated univentricular heart physiology.Additional files
Additional file 1: Video S1. Particle trace in the Fontan circuit.
Particle trace released in the Fontan circulation in a patient with hypoplastic
left heart syndrome. Visual examination of the particles provides insight about
the flow dynamics. Note the whirl flow originated in the confluence between
the superior and the inferior vena cava. Some particles from the inferior vena
cava shunt to the right atrium through the fenestration.
Additional file 2: Video S2. Particle trace in the pulmonary veins and
aorta. Particle trace evaluation in the pulmonary veins and aorta in a patient
with hypoplastic left heart syndrome. Note the blood flow entering into the
ventricle and being pumped through the aorta. The laminar flow is well
preserved in the ascending and transverse arch with no major areas of
turbulent flow seen.
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